Liver Failure and Liver Disease

You have full text access to this OnlineOpen article

Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study†‡

  1. Anne M. Larson1,§,*,
  2. Julie Polson2,
  3. Robert J. Fontana3,
  4. Timothy J. Davern4,
  5. Ezmina Lalani2,
  6. Linda S. Hynan5,
  7. Joan S. Reisch5,
  8. Frank V. Schiødt2,
  9. George Ostapowicz2,
  10. A. Obaid Shakil6,
  11. William M. Lee2

Article first published online: 29 NOV 2005

DOI: 10.1002/hep.20948

Issue

Hepatology

Hepatology

Volume 42, Issue 6, pages 1364–1372, December 2005

Additional Information

How to Cite

Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., Reisch, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O. and Lee, W. M. (2005), Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology, 42: 1364–1372. doi: 10.1002/hep.20948

Author Information

  1. 1

    Department of Internal Medicine, Division of Gastroenterology, University of Washington Medical Center, Seattle WA

  2. 2

    Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TX

  3. 3

    Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI

  4. 4

    Department of Internal Medicine, Division of Gastroenterology, University of California at San Francisco, San Francisco, CA

  5. 5

    Center for Biostatistics and Clinical Science, University of Texas Southwestern Medical Center, Dallas, TX

  6. 6

    Department of Medicine, Division of Gastroenterology, University of Pittsburgh Medical Center, Pittsburgh, PA

  1. §

    fax: 206-598-3884

*University of Washington, Box 356174, Room EE-425, 1959 NE Pacific St., Seattle, WA 98195-6174

  1. †

    See Editorial on Page 1252.

  2. ‡

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 29 NOV 2005
  2. Article first published online: 29 NOV 2005
  3. Manuscript Accepted: 12 SEP 2005
  4. Manuscript Received: 24 JUN 2005

Funded by

  • NIDDK. Grant Number: R-01-DK58639
  • Stephen B. Tips Fund at Northwestern University
  • FDA. Grant Number: FD-R-001661
  • NIH. Grant Numbers: R-O3 DK52827, R-01 DK58369
  • Stephen B. Tips Fund of Northwestern Medical Foundation
  • Jeanne Roberts Fund of the Southwestern Medical Foundation
  • AASLD/Schering Research Fellowship

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (147K)

References

  • 1
    Black M. Acetaminophen hepatotoxicity. Annu Rev Med 1984; 35: 577–593.
  • 2
    Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966; 5512: 497–499.
  • 3
    Thomson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J 1966; 5512: 506–507.
  • 4
    Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. HEPATOLOGY 1995; 22: 767–773.
    Direct Link:
  • 5
    Maddrey WC. Hepatic effects of acetaminophen. Enhanced toxicity in alcoholics. J Clin Gastroenterol 1987; 9: 180–185.
  • 6
    Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845–1850.
  • 7
    Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital N Engl J Med 1997; 337: 1112–1117.
  • 8
    Rumack BH. Acetaminophen misconceptions. HEPATOLOGY 2004; 40: 10–15.
    Direct Link:
  • 9
    Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346: 547–552.
  • 10
    Schiodt FV, Bondesen S, Tygstrup N, Christensen E. Prediction of hepatic encephalopathy in paracetamol overdose: a prospective and validated study. Scand J Gastroenterol 1999; 34: 723–728.
  • 11
    Ritt DJ, Whelan G, Werner DJ, Eigenbrodt EH, Schenker S, Combes B. Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine (Baltimore) 1969; 48: 151–172.
  • 12
    Rakela J, Perkins JD, Gross JB, Jr, Hayes DH, Plevak DJ, Krom RA, et al. Acute hepatic failure: the emerging role of orthotopic liver transplantation. Mayo Clin Proc 1989; 64: 424–428.
  • 13
    Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29–34.
    Direct Link:
  • 14
    Quallich LG, Shehab TM, Brown JW, Fontana RJ. Management of Acetaminophen Hepatotoxicity: A Survey of Practicing Physicians. J Clin Outcomes Management 2001: 25–32.
  • 15
    Trey C, Davidson CS. The management of fulminant hepatic failure. In: PopperH, SchaffnerF, eds. Progress in Liver Diseases. New York: Grune & Stratton, 1970: 282–292.
  • 16
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947–954.
  • 17
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829.
  • 18
    O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439–445.
  • 19
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464–470.
    Direct Link:
  • 20
    Williams R, Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. HEPATOLOGY 1994; 20: S5–10S.
  • 21
    Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med 1997; 42: 453–483.
  • 22
    Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163–169.
  • 23
    US Department of Health and Human Services (DHHS). Third National Health and Nutrition Examination Survey, 1988–1994, NHANES III Second Laboratory Data File. (CD-ROM, Series 11, No 2A). Hyattsville, MD: Centers for Disease Control and Prevention, 1998.
  • 24
    Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose. Q J Med 2000; 93: 341–349.
  • 25
    Larsen FS, Kirkegaard P, Rasmussen A, Hansen BA. The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transplant Proc 1995; 27: 3519–3520.
  • 26
    Gow PJ, Jones RM, Dobson JL, Angus PW. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol 2004; 19: 154–159.
    Direct Link:
  • 27
    Shayiq RM, Roberts DW, Rothstein K, Snawder JE, Benson W, Ma X, et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. HEPATOLOGY 1999; 29: 451–463.
    Direct Link:
  • 28
    Csete M, Sullivan JB. Vicodin-induced fulminant hepatic failure. Anesthesiology 1993; 79: 857–860.
  • 29
    Block R, Jankowski JA, Lacoux P, Pennington CR. Does hypothermia protect against the development of hepatitis in paracetamol overdose? Anaesthesia 1992; 47: 789–791.
    Direct Link:
  • 30
    Court MH, Duan SX, Von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, et al. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 2001; 299: 998–1006.
  • 31
    Acuna G, Foernzler D, Leong D, Rabbia M, Smit R, Dorflinger E, et al. Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity. Pharmacogenomics J 2002; 2: 327–334.
  • 32
    Chen L, Schneider S, Wax P. Knowledge about acetaminophen toxicity among emergency department visitors. Vet Hum Toxicol 2002; 44: 370–373.
  • 33
    Hawton K, Townsend E, Deeks J, Appleby L, Gunnell D, Bennewith O, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 2001; 322: 1203–1207.
  • 34
    Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. HEPATOLOGY 2002; 35: 876–882.
    Direct Link:
  • 35
    Thummel KE, Slattery JT, Ro H, Chien JY, Nelson SD, Lown KE, et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 2000; 67: 591–599.
  • 36
    Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 2000; 49: 291–301.
    Direct Link:
  • 37
    Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996; 16: 343–348.
  • 38
    Schiodt FV, Lee WM. Management of acetaminophen toxicity. In: KrawittE, ed. Medical Management of Liver Disease. New York: Marcel Dekker, 1999: 325–337.
  • 39
    Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 1993; 17: 124–127.
  • 40
    Mitchell I, Bihari D, Chang R, Wendon J, Williams R. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998; 26: 279–284.
  • 41
    Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis 2003; 23: 227–237.
  • 42
    Wilkinson S, Taylor G, Templeton L, Mistral W, Salter E, Bennett P. Admissions to hospital for deliberate self-harm in England 1995–2000: an analysis of hospital episode statistics. J Public Health Med 2002; 24: 179–183.
  • 43
    Gunnell D, Hawton K, Murray V, Garnier R, Bismuth C, Fagg J, et al. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health 1997; 51: 175–179.
  • 44
    Sheen CL, Dillon JF, Bateman DN, Simpson KJ, MacDonald TM. Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002; 11: 329–331.
    Direct Link:
  • 45
    Robinson D, Smith AM, Johnston GD. Severity of overdose after restriction of paracetamol availability: retrospective study. BMJ 2000; 321: 926–927.
  • 46
    Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 2004; 329: 1076.
View Full Article (HTML) Get PDF (147K)